Here’s whether 10x Genomics, Inc. Class A Common Stock (TXG) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.64% over 10 days); RSI 61 — healthy momentum range; strong 1-year return of +177.3%; 3-month momentum positive (+24.0%). Currently 10.5% off its 52-week high. Score: +7/7.
TXG is in a confirmed uptrend, trading above both its 50-day ($21.70) and 200-day ($17.60) moving averages. An RSI of 61.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +177.3% compares to +27.9% for SPY (beat the market by 149.4%).
$10,000 invested 1 year ago→ $27,728 today
vs. S&P 500 (SPY) — same period beat market by 149.4%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($17.60)
✓Above 50-day MA ($21.70)
✓RSI(14) neutral zone (30–70) — currently 61.1
✓Positive return (+177.3%)
!Within 10% of period high (−10.5%)
Period Range $23.68
$8.07$26.45
RSI (14) 61.1
0 · OversoldOverbought · 100
Key Metrics
Price$23.68
Period Return+177.3%
Period High$26.45
Period Low$8.07
Drawdown−10.5%
MA-50$21.70
MA-200$17.60
RSI (14)61.1
Avg Volume (30d)2.8M
vs. SPYbeat by 149.4%
Return Rank#137 of 1236
Trend Signals
Price is above the 200-day moving average ($17.60)